The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections that led to the coronavirus disease-2019 (COVID-19, also known as 2019 nCoV) outbreak in Wuhan City, China, has spread quickly throughout the world. The Huanan Seafood Wholesale Market in Wuhan was epidemiologically linked to the majority of patients from the first cluster. The evidence that is now available indicates that SARS-CoV-2 can spread easily from person to person through close contact and respiratory droplets, posing a significant threat to public health. SARS-CoV-2 research is still in its early phases at the moment. Dexa-methasone and remdesivir, however, seem to be effective medicinal treatments. There is still no clear-cut cure, and supportive therapy continues to be the cornerstone of care. Over 150 vaccinations are now being looked upon. In order to successfully manage the condition, it is vital to comprehend the nature of the virus and its clinical traits. Clinicians must keep up with the fast changing body of knowledge regarding this infection. Based on the most recent research, the present review provides a thorough summary of the epidemiology, etiology, clinical features, and therapy of COVID-19.
